Haemonetics (HAE) Other Non-Current Assets (2010 - 2026)

Haemonetics has reported Other Non-Current Assets for 17 years, with the latest figure at $150.0 million in Q2 2026.

• On a quarterly basis, Other Non-Current Assets fell 23.6% year-over-year to $150.0 million in Q2 2026; TTM through Jun 2026 was $150.0 million, a 23.6% decrease from a year earlier, with the FY2026 full-year figure at $141.7 million, down 13.63% from the prior year.
• Other Non-Current Assets was $150.0 million for Q2 2026 at Haemonetics, up from $141.7 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $216.1 million in Q4 2025, with the low at $63.2 million in Q2 2022.
• Average Other Non-Current Assets over 5 years is $132.7 million, with a median of $136.4 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2026: Other Non-Current Assets soared 69.25% in 2023, then decreased 23.6% in 2026.
• Over 5 years, Other Non-Current Assets stood at $103.3 million in 2022, then increased by 23.39% to $127.4 million in 2023, then climbed by 25.87% to $160.4 million in 2024, then soared by 34.71% to $216.1 million in 2025, then plunged by 30.6% to $150.0 million in 2026.
• The last three Other Non-Current Assets figures came in at $150.0 million (Q2 2026), $141.7 million (Q1 2026), and $216.1 million (Q4 2025), per Business Quant data.